Management of immunotherapy toxicity: European Society for Medical Oncology (ESMO) clinical guidelines for diagnosis, treatment and patient follow-up
Summary. This European Society for Medical Oncology (ESMO) review provides key clinical guidelines for the management of immunotherapy-related toxicities, including the assessment, diagnosis, and management of the most common serious adverse events (AEs) associated with immunotherapy. The recommendations are based on available scientific data and the collective expert opinion of an interdisciplinary group of experts from various institutions in Europe, Australia, and the United States.
Leave a comment